Delayed Melanoma Care During Pandemic Proved Costly
By Lori Solomon HealthDay Reporter
TUESDAY, Feb. 27, 2024 -- Delays in melanoma diagnoses due to COVID-19 pandemic lockdowns were associated with a significant burden, including years of life lost and costs, according to a study published online Feb. 16 in JAMA Network Open.
Lara V. Maul, M.D., from University Hospital of Basel in Switzerland, and colleagues examined the consequences associated with delays in melanoma screenings during pandemic-related lockdowns. The analysis included data from 50,072 adults with invasive primary cutaneous melanomas stages I to IV from Switzerland (January 2017 to December 2021) and Hungary (January 2019 to December 2021).
The researchers found an estimated 111,464 years of life lost (YLL) due to pandemic-associated delay in melanoma diagnosis in Europe, with estimated total additional costs of $7.65 billion. The main cost driver was indirect treatment costs, accounting for 94.5 percent of total costs. There were 15,360 years lost due to disability (YLD) for the 17 percent upstaging model. The overall disease burden (YLL plus YLD) was 126,824 disability-adjusted life-years for the real-world 17 percent scenario.
"This economic analysis emphasizes the importance of continuing secondary skin cancer prevention measures during pandemics," the authors write. "Beyond the personal outcomes of a delayed melanoma diagnosis, the additional economic and public health consequences are underscored, emphasizing the need to include indirect economic costs in future decision-making processes."
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Further Support and Information on COVID-19
Read this next
COVID-19 Treatment Guidelines Show Great Global Variance
THURSDAY, April 25, 2024 -- There is significant global variation in COVID-19 treatment recommendations and disease severity stratifications, according to a study published online...
Pandemic Had Modest Effect on Early Childhood Development Milestones
MONDAY, April 22, 2024 -- Modest changes were seen in early childhood development milestone achievement during the COVID-19 pandemic, according to a study published online April...
Pediatric Mental Health ED Visits Lower Than Expected in Late Pandemic
MONDAY, April 15, 2024 -- Pediatric mental health (MH) emergency department visits were lower during the late pandemic period than prepandemic, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.